Oncotarget is a peer review journal published by Impact Journals. Oncotarget was first founded in 2010 by Mikhail Blagosklonny and Andrei V. Gudkov of the Roswell Park Cancer Institute. These two physicians are the editors in chief of the journal as well as researchers in the area of cancer and aging. The term “oncotarget” was chosen as the name of the journal because it encompasses all the cellular pathways, functions and molecules that are involved in aging and cancer. The journal can be accessed by the public for free. Oncotarget can easily be accessed online at http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget. Articles and supplemental information such as author interviews can also be accessed from the website and learn more about Oncotarget.
The journal is a multidisciplinary journal, allowing different fields of biomedical science to be linked together. Besides oncology, the journal also publishes studies in the fields of neuroscience, genetics, endocrinology, cardiology, metabolism, microbiology, cell biology, pathology, and pharmacology. As a result of its popularity and relevance to the scientific community, the weekly journal has increased its publishing schedule to twice a week or bi-weekly and what Oncotarget knows.
Mikhail Blagosklonny and Andrei V. Gudkov created Oncotarget in order to allow scientific results to be easily accessed and shared in a timely manner, as well as, allowing these findings to be globally available. They also wanted new and innovative applications to treat disease and other important clinical findings to be peer reviewed by knowledgeable colleagues to maximize its the impact of the research and more information click here.
The goal of the journal is to assist researchers in contributing to the progression of science and the elimination of disease and Oncotarget’s lacrosse camp.
More Visit: https://oncotarget.msubmit.net/cgi-bin/main.plex